Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization

Lori A. Erickson, Syed M. Jalal, John R. Goellner, Mark E. Law, Aaron Harwood, Long Jin, Patrick C. Roche, Ricardo V. Lloyd

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Recent studies have indicated that numerical chromosomal abnormalities including changes in p53 and cyclin D1 may be involved in Hurthle cell tumorigenesis. We analyzed a series of Hurthle cell neoplasms of the thyroid to evaluate the diagnostic and prognostic utility of numerical anomalies by DNA fluorescent probes for cyclin D1 and p53 gene loci and chromosomes 5, 7, 11, 12, 17, and 22. Interphase fluorescence in situ hybridization (FISH) analysis was performed on paraffin-embedded tissue sections from 10 Hurthle cell adenomas, 19 Hurthle cell carcinomas, and 7 normal thyroid tissues used as controls. Directly labeled fluorescent DNA probes for the centromere region of chromosomes 7, 11, 12, and 17 and locus-specific probes for chromosomes 5 and 22, cyclin D1, and p53 were utilized for dual-probe hybridizations. Sixty percent (6 of 10) Hurthle cell adenomas and 63% (12 of 19) Hurthle cell carcinomas showed chromosome gains. Twenty percent (2 of 10) Hurthle cell adenomas and 26% (5 of 19) Hurthle cell carcinomas showed chromosome losses. Normal thyroid tissues used as controls showed no chromosomal abnormalities. Among Hurthle cell tumors with chromosomal abnormalities, adenomas averaged 2.7 gains and 0.3 losses per case, and carcinomas averaged 3.3 gains and 0.6 losses per case. The two adenomas with chromosome losses each showed loss of one chromosome, whereas the five carcinomas with losses averaged 1.8 losses per case. Chromosome 22 was the most common loss identified, occurring in three of the 11 patients who died of disease. These results indicate that chromosomal imbalances as gains are common in both benign and malignant Hurthle cell neoplasms, but Hurthle cell carcinomas tend to have more chromosome losses than adenomas. Among Hurthle cell carcinomas in this study, chromosome losses were identified only from patients who died of disease. The loss of chromosome 22 may have prognostic value in Hurthle cell carcinoma of the thyroid.

Original languageEnglish (US)
Pages (from-to)911-917
Number of pages7
JournalAmerican Journal of Surgical Pathology
Volume25
Issue number7
DOIs
StatePublished - 2001

Fingerprint

Oxyphil Cells
Interphase
Fluorescence In Situ Hybridization
Thyroid Neoplasms
Adenoma
Carcinoma
Chromosomes
Chromosomes, Human, Pair 22
Chromosome Aberrations
Chromosomes, Human, Pair 5
Chromosomes, Human, Pair 7
Cyclin D1
DNA Probes
Fluorescent Dyes
Thyroid Gland
bcl-1 Genes
Oxyphilic Adenoma
Chromosomes, Human, Pair 11
Centromere
p53 Genes

Keywords

  • Fluorescence in situ hybridization
  • Hurthle cell
  • Thyroid

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Erickson, L. A., Jalal, S. M., Goellner, J. R., Law, M. E., Harwood, A., Jin, L., ... Lloyd, R. V. (2001). Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization. American Journal of Surgical Pathology, 25(7), 911-917. https://doi.org/10.1097/00000478-200107000-00009

Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization. / Erickson, Lori A.; Jalal, Syed M.; Goellner, John R.; Law, Mark E.; Harwood, Aaron; Jin, Long; Roche, Patrick C.; Lloyd, Ricardo V.

In: American Journal of Surgical Pathology, Vol. 25, No. 7, 2001, p. 911-917.

Research output: Contribution to journalArticle

Erickson, LA, Jalal, SM, Goellner, JR, Law, ME, Harwood, A, Jin, L, Roche, PC & Lloyd, RV 2001, 'Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization', American Journal of Surgical Pathology, vol. 25, no. 7, pp. 911-917. https://doi.org/10.1097/00000478-200107000-00009
Erickson, Lori A. ; Jalal, Syed M. ; Goellner, John R. ; Law, Mark E. ; Harwood, Aaron ; Jin, Long ; Roche, Patrick C. ; Lloyd, Ricardo V. / Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization. In: American Journal of Surgical Pathology. 2001 ; Vol. 25, No. 7. pp. 911-917.
@article{fcbd2faed536413a9fe0f0385e13d159,
title = "Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization",
abstract = "Recent studies have indicated that numerical chromosomal abnormalities including changes in p53 and cyclin D1 may be involved in Hurthle cell tumorigenesis. We analyzed a series of Hurthle cell neoplasms of the thyroid to evaluate the diagnostic and prognostic utility of numerical anomalies by DNA fluorescent probes for cyclin D1 and p53 gene loci and chromosomes 5, 7, 11, 12, 17, and 22. Interphase fluorescence in situ hybridization (FISH) analysis was performed on paraffin-embedded tissue sections from 10 Hurthle cell adenomas, 19 Hurthle cell carcinomas, and 7 normal thyroid tissues used as controls. Directly labeled fluorescent DNA probes for the centromere region of chromosomes 7, 11, 12, and 17 and locus-specific probes for chromosomes 5 and 22, cyclin D1, and p53 were utilized for dual-probe hybridizations. Sixty percent (6 of 10) Hurthle cell adenomas and 63{\%} (12 of 19) Hurthle cell carcinomas showed chromosome gains. Twenty percent (2 of 10) Hurthle cell adenomas and 26{\%} (5 of 19) Hurthle cell carcinomas showed chromosome losses. Normal thyroid tissues used as controls showed no chromosomal abnormalities. Among Hurthle cell tumors with chromosomal abnormalities, adenomas averaged 2.7 gains and 0.3 losses per case, and carcinomas averaged 3.3 gains and 0.6 losses per case. The two adenomas with chromosome losses each showed loss of one chromosome, whereas the five carcinomas with losses averaged 1.8 losses per case. Chromosome 22 was the most common loss identified, occurring in three of the 11 patients who died of disease. These results indicate that chromosomal imbalances as gains are common in both benign and malignant Hurthle cell neoplasms, but Hurthle cell carcinomas tend to have more chromosome losses than adenomas. Among Hurthle cell carcinomas in this study, chromosome losses were identified only from patients who died of disease. The loss of chromosome 22 may have prognostic value in Hurthle cell carcinoma of the thyroid.",
keywords = "Fluorescence in situ hybridization, Hurthle cell, Thyroid",
author = "Erickson, {Lori A.} and Jalal, {Syed M.} and Goellner, {John R.} and Law, {Mark E.} and Aaron Harwood and Long Jin and Roche, {Patrick C.} and Lloyd, {Ricardo V.}",
year = "2001",
doi = "10.1097/00000478-200107000-00009",
language = "English (US)",
volume = "25",
pages = "911--917",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization

AU - Erickson, Lori A.

AU - Jalal, Syed M.

AU - Goellner, John R.

AU - Law, Mark E.

AU - Harwood, Aaron

AU - Jin, Long

AU - Roche, Patrick C.

AU - Lloyd, Ricardo V.

PY - 2001

Y1 - 2001

N2 - Recent studies have indicated that numerical chromosomal abnormalities including changes in p53 and cyclin D1 may be involved in Hurthle cell tumorigenesis. We analyzed a series of Hurthle cell neoplasms of the thyroid to evaluate the diagnostic and prognostic utility of numerical anomalies by DNA fluorescent probes for cyclin D1 and p53 gene loci and chromosomes 5, 7, 11, 12, 17, and 22. Interphase fluorescence in situ hybridization (FISH) analysis was performed on paraffin-embedded tissue sections from 10 Hurthle cell adenomas, 19 Hurthle cell carcinomas, and 7 normal thyroid tissues used as controls. Directly labeled fluorescent DNA probes for the centromere region of chromosomes 7, 11, 12, and 17 and locus-specific probes for chromosomes 5 and 22, cyclin D1, and p53 were utilized for dual-probe hybridizations. Sixty percent (6 of 10) Hurthle cell adenomas and 63% (12 of 19) Hurthle cell carcinomas showed chromosome gains. Twenty percent (2 of 10) Hurthle cell adenomas and 26% (5 of 19) Hurthle cell carcinomas showed chromosome losses. Normal thyroid tissues used as controls showed no chromosomal abnormalities. Among Hurthle cell tumors with chromosomal abnormalities, adenomas averaged 2.7 gains and 0.3 losses per case, and carcinomas averaged 3.3 gains and 0.6 losses per case. The two adenomas with chromosome losses each showed loss of one chromosome, whereas the five carcinomas with losses averaged 1.8 losses per case. Chromosome 22 was the most common loss identified, occurring in three of the 11 patients who died of disease. These results indicate that chromosomal imbalances as gains are common in both benign and malignant Hurthle cell neoplasms, but Hurthle cell carcinomas tend to have more chromosome losses than adenomas. Among Hurthle cell carcinomas in this study, chromosome losses were identified only from patients who died of disease. The loss of chromosome 22 may have prognostic value in Hurthle cell carcinoma of the thyroid.

AB - Recent studies have indicated that numerical chromosomal abnormalities including changes in p53 and cyclin D1 may be involved in Hurthle cell tumorigenesis. We analyzed a series of Hurthle cell neoplasms of the thyroid to evaluate the diagnostic and prognostic utility of numerical anomalies by DNA fluorescent probes for cyclin D1 and p53 gene loci and chromosomes 5, 7, 11, 12, 17, and 22. Interphase fluorescence in situ hybridization (FISH) analysis was performed on paraffin-embedded tissue sections from 10 Hurthle cell adenomas, 19 Hurthle cell carcinomas, and 7 normal thyroid tissues used as controls. Directly labeled fluorescent DNA probes for the centromere region of chromosomes 7, 11, 12, and 17 and locus-specific probes for chromosomes 5 and 22, cyclin D1, and p53 were utilized for dual-probe hybridizations. Sixty percent (6 of 10) Hurthle cell adenomas and 63% (12 of 19) Hurthle cell carcinomas showed chromosome gains. Twenty percent (2 of 10) Hurthle cell adenomas and 26% (5 of 19) Hurthle cell carcinomas showed chromosome losses. Normal thyroid tissues used as controls showed no chromosomal abnormalities. Among Hurthle cell tumors with chromosomal abnormalities, adenomas averaged 2.7 gains and 0.3 losses per case, and carcinomas averaged 3.3 gains and 0.6 losses per case. The two adenomas with chromosome losses each showed loss of one chromosome, whereas the five carcinomas with losses averaged 1.8 losses per case. Chromosome 22 was the most common loss identified, occurring in three of the 11 patients who died of disease. These results indicate that chromosomal imbalances as gains are common in both benign and malignant Hurthle cell neoplasms, but Hurthle cell carcinomas tend to have more chromosome losses than adenomas. Among Hurthle cell carcinomas in this study, chromosome losses were identified only from patients who died of disease. The loss of chromosome 22 may have prognostic value in Hurthle cell carcinoma of the thyroid.

KW - Fluorescence in situ hybridization

KW - Hurthle cell

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=0034957083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034957083&partnerID=8YFLogxK

U2 - 10.1097/00000478-200107000-00009

DO - 10.1097/00000478-200107000-00009

M3 - Article

C2 - 11420462

AN - SCOPUS:0034957083

VL - 25

SP - 911

EP - 917

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 7

ER -